Ocular Melanoma Epidemiology Forecast 2026-2035

Ocular melanoma is a rare but serious malignancy of the eye, primarily affecting the uveal tract. As per Massive Bio, global incidence is estimated at 4.3-5.1 cases per million annually, with 5-year survival rates ranging from 60% to 80%. According to the ocular melanoma epidemiology forecast, outcomes vary significantly based on tumor stage and clinical characteristics at diagnosis.

Ocular Melanoma Epidemiology Forecast Report Coverage

The analyst's “Ocular Melanoma Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of ocular melanoma. It projects the future incidence and prevalence rates of ocular melanoma cases across various populations. The study covers age, gender, and type as major determinants of the ocular melanoma population. The report highlights patterns in the prevalence of ocular melanoma over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of ocular melanoma in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Ocular Melanoma Understanding: Disease Overview

Ocular melanoma is a rare malignancy arising from melanocytes within the eye, most commonly affecting the uveal tract, which includes the iris, ciliary body, and choroid. It occurs due to genetic mutations that trigger the uncontrolled proliferation of pigment-producing cells. The disease is classified into uveal melanoma (the most prevalent form) and conjunctival melanoma, which develops on the eye’s outer membrane. Risk factors include light eye color, ultraviolet exposure, and genetic predisposition. Early stages are often asymptomatic, while advanced disease may cause visual disturbances or metastasize, particularly to the liver.

Ocular Melanoma Epidemiology Perspective

The ocular melanoma epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the ocular melanoma epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for ocular melanoma and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the American Cancer Society, ocular melanoma contributes to approximately 3,200 new eye and orbit cancer cases in 2026, with about 530 associated deaths, reflecting its low prevalence but measurable mortality burden among rare cancers.
• As per Dharti R. Patel et al., 2024, the incidence is approximately 5 cases per million population in the United States and 7.5 per million in northern European populations, indicating notable geographic and ethnic variation.
• According to Kauvery Hospital, the median age at diagnosis is around 62 years, with peak incidence observed between 70 and 79 years, demonstrating a strong age-related pattern primarily affecting older adults.
• As per Bożena Romanowska-Dixon et al., 2023, females account for 54.34% of cases, while males show a higher likelihood of advanced tumor characteristics and more frequent surgical removal of the eye.
• According to Yifan Wu et al., 2025, choroidal melanoma represents nearly 85% of ocular melanoma cases and is associated with increased disease-specific and all-cause mortality, underscoring its aggressive clinical course.

Country-wise Ocular Melanoma Epidemiology

The ocular melanoma epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of ocular melanoma across regions demonstrates clear regional variation in incidence and prevalence. According to Basilica M. Arockiaraj et al., 2024, approximately 2,000 new cases are diagnosed annually in the United States. As per Massive Bio, higher incidence rates are observed in North America and Europe, particularly among white populations, including the United Kingdom, Germany, France, Spain, and Italy. In contrast, comparatively lower incidence rates are reported in Japan and India. Overall prevalence remains relatively stable, with modest increases in certain regions attributed to improved diagnostic capabilities and an aging population, highlighting persistent geographic disparities.

Ocular Melanoma: Treatment Overview

Treatment of ocular melanoma depends on tumor size, location, and extent of spread, with the primary goal of preserving vision and preventing metastasis. Common approaches include radiation therapy, particularly plaque brachytherapy and proton beam therapy, which target tumor cells while sparing surrounding tissues. Surgical options, such as local resection or enucleation, are considered for larger or advanced tumors. Laser therapies, including transpupillary thermotherapy, may be used in selected cases. Systemic treatments, such as immunotherapy and targeted therapy, are increasingly utilized for metastatic disease, with emerging evidence suggesting improvements in patient outcomes and survival.

Key Questions Answered

• What are the key findings of ocular melanoma epidemiology in the 8 major markets?
• What will be the total number of patients with ocular melanoma across the 8 major markets during the forecast period?
• What was the country-wise ocular melanoma epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of ocular melanoma patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of ocular melanoma during the forecast period of 2026-2035?
• What are the currently available treatments for ocular melanoma?
• What are the disease risks, signs, symptoms, and unmet needs of ocular melanoma?

Scope of the Ocular Melanoma Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of ocular melanoma based on several factors.
• Ocular Melanoma Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The ocular melanoma report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.